Deng Hongkui

Deng Hongkui is a distinguished cellular biologist leading a research team at Peking University, known for groundbreaking work in regenerative medicine and diabetes treatment. He recently gained international attention for leading a successful clinical trial where a 25-year-old woman with type 1 diabetes started producing her own insulin after receiving a transplant of her own reprogrammed cells, marking a significant milestone in the potential treatment of this challenging autoimmune disease.